BMY Long Play
Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis.
Investments continue to flow into the healthcare industry and BMY is ripe to benefit. Adding it long
Investments continue to flow into the healthcare industry and BMY is ripe to benefit. Adding it long
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.